BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
CytRx Corporation (CYTR) To Present At Biocentury's 2014 Newsmakers In The Biotech Industry Conference 9/19/2014 7:59:30 AM
CytRx Corporation (CYTR) Initiates Phase 1b Clinical Trial With Combination Of Aldoxorubicin And Ifosfamide/Mesna As First-Line Treatment In Patients With Advanced Sarcomas 9/9/2014 10:58:14 AM
CytRx Corporation (CYTR) Updates Presentation Time At Aegis 2014 Healthcare & Technology Conference 9/5/2014 11:08:57 AM
CytRx Corporation (CYTR) To Present At Upcoming Investor Conferences In New York City And Las Vegas 9/2/2014 1:51:08 PM
Oral Presentation Of CytRx Corporation (CYTR)’s Aldoxorubicin Phase 2b Clinical Trial In Soft Tissue Sarcoma Highlighted In The Lancet Oncology 8/7/2014 10:06:35 AM
CytRx Corporation (CYTR) Reports 2014 Second Quarter Financial Results 8/6/2014 9:21:07 AM
CytRx Corporation (CYTR) Added To Russell 3000® And Russell 2000® Indexes 6/30/2014 11:27:39 AM
CytRx Corporation (CYTR) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 7:30:04 AM
CytRx Corporation (CYTR) Highlights Aldoxorubicin Data From Its Global Phase 2b Clinical Trial In First-Line Soft Tissue Sarcoma 5/28/2014 9:08:59 AM
CytRx Corporation (CYTR) Reports Completed Phase 1b/2 Progression-Free Survival And Overall Survival Aldoxorubicin Data In Second-Line Soft Tissue Sarcoma 5/5/2014 9:00:37 AM
12345678910...